APOE genotype is a major predictor of long-term progression of disability in MS
about
sameAs
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseAging, neurodegenerative disease, and traumatic brain injury: the role of neuroimagingAssociation of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosisApolipoprotein E plays a key role against cryptosporidial infection in transgenic undernourished miceSmall-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathologyCognitive impairments in multiple sclerosis: a review.A second-generation genomic screen for multiple sclerosisThe immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury.Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.The pathology of primary progressive multiple sclerosis.Function and comorbidities of apolipoprotein e in Alzheimer's disease.Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.Multiple sclerosis genetics: leaving no stone unturned.Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).The association between apolipoprotein E and multiple sclerosis.Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions.Apolipoprotein e sets the stage: response to injury triggers neuropathology.The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol.COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brainThe epidemiology of chronic daily headache.APOE genotype-specific differences in the innate immune responseMultiple sclerosis in the elderly patient.Apolipoprotein E and central nervous system disorders: reviews of clinical findings.Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review.The role of apolipoprotein E in neurodegeneration and cardiovascular disease.Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients.Apolipoprotein E Mimetic Promotes Functional and Histological Recovery in Lysolecithin-Induced Spinal Cord Demyelination in Mice.APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer diseaseAllelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis.Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis.Association of refractory complex partial seizures with a polymorphism of ApoE genotype.No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis.Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin.
P2860
Q22248091-9F055CC1-6BC6-45A6-B211-774C76518EF3Q26828882-CD54F236-AD0D-42FE-8813-175E18E5AFEAQ28218229-5C5D1F2C-128A-4923-8DDE-3A23CF4C453CQ30414421-77945AB6-E53E-4ED2-82AB-E64F83269892Q30421643-0A8D6597-2F5B-4BAE-9EC8-D416159DD302Q30671631-33EAC128-57DF-48FD-858A-ACF4F80B7D98Q33910544-5EBE75B7-1FE2-47DD-B51C-462AD6BA7709Q33960847-F69C7DC4-3CCC-4F2A-813E-2AF99E915566Q34028091-F56546FF-4C73-4F24-B9CE-9D6EAF91E70BQ34156824-FE706A2F-685B-4DF7-96EE-423B9CC8BC76Q34621541-DD6B9D46-D2AC-448B-A9A6-BC714EF27BA8Q34625041-DBF08EB3-5520-48BA-8D2D-E8B6E957C23CQ34951817-370BFE3F-10CA-476C-9E05-199B37A4F068Q35763180-CCFCCC88-4B52-4974-8335-D67E63191D87Q36171871-A41018E0-5557-4D26-ADDB-F635DBAF28DEQ36212078-8FFF23E0-8A82-46F0-8982-7536A3B02BACQ36504889-1D332FFD-0F30-478F-9D88-EFE20BBDAA52Q36516912-BD104962-1153-411D-9509-C6180F4A0D28Q36727013-0E3182AE-C292-4953-BB3B-F607C4008908Q36918114-91CEB440-94E1-4F18-9604-8008BFFAA9C7Q36963238-B934EFE4-9B74-4EF3-8EA6-B77DBA8AD646Q37003279-634E9171-BB63-4A38-8D95-D3EDC9F681F8Q37357906-47A84701-1ECF-4919-8958-73CEF42B4D2EQ37363473-EE8DD0DC-1998-47BB-991F-8DEE4D774CBEQ37434999-65DC4970-BFC9-4353-9005-A9A8A5A3BBC5Q37722747-6AFAF5D1-C2CF-4940-9B80-DA7F029FE8CBQ37812145-94298004-8B29-434E-A554-C00C2A9A6221Q38167677-897FE247-C322-4941-9C36-1B99A6555D6CQ38206263-889C4E28-37D2-4C65-A5B9-7419867E82AAQ38659590-AEDBBB10-E4E2-4BC7-AC56-286C8EFC5E39Q40561053-3C50FB49-A07F-497C-A78D-10163CE8060BQ41494940-3BF1FDE6-28E7-4E78-BA6D-AA7D52B4FF02Q41866014-3018299E-9E45-479E-930D-C15CCF76F978Q45416078-20644BF2-A635-40C3-8250-FA36735521AFQ46548630-7CC937FD-C294-4C45-9969-139D964D2CF2Q46733684-AC90CAD0-7208-4F5B-961E-252762A14F5FQ47276347-E59E2345-775E-4DA0-8A78-AA46F15A2AD3Q47276359-29D69CE5-900C-4F65-96D7-B2BDD596BAB3Q47619892-B2881B92-3CC1-4EDB-974C-7EFF595668E3Q47655500-507560F2-D5DF-40BD-A48F-BAD149618FBF
P2860
APOE genotype is a major predictor of long-term progression of disability in MS
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
APOE genotype is a major predictor of long-term progression of disability in MS
@ast
APOE genotype is a major predictor of long-term progression of disability in MS
@en
APOE genotype is a major predictor of long-term progression of disability in MS
@nl
type
label
APOE genotype is a major predictor of long-term progression of disability in MS
@ast
APOE genotype is a major predictor of long-term progression of disability in MS
@en
APOE genotype is a major predictor of long-term progression of disability in MS
@nl
prefLabel
APOE genotype is a major predictor of long-term progression of disability in MS
@ast
APOE genotype is a major predictor of long-term progression of disability in MS
@en
APOE genotype is a major predictor of long-term progression of disability in MS
@nl
P2093
P356
P1433
P1476
APOE genotype is a major predictor of long-term progression of disability in MS
@en
P2093
D M Karussis
D M Michaelson
K Mitosek-Szewczyk
M Birnbaum
S Vinokurov
P356
10.1212/WNL.56.3.312
P407
P577
2001-02-13T00:00:00Z